August 2026 | Proven Knockout: Bench-Validated Cas9 RNP Delivery
At RJH Biosciences, we design polymer-based nucleic acid delivery platforms to enable high-efficiency gene editing in primary and hard-to-transfect cell lines. CRISP-Fect provides a robust,
July 2026 | “Safety-First” Transfection Reagents: Validated, Trusted Technology
At RJH Biosciences, we develop non-viral, polymer-based nucleic acid delivery systems designed for efficient transfection of primary and hard-to-transfect cells. Our platform enables robust delivery
May 2026 | Efficient Nucleic Acid Delivery in Primary Cells
At RJH Biosciences, we develop non-viral, polymer-based nucleic acid delivery systems designed for efficient transfection of primary and hard-to-transfect cells. Our platform enables robust delivery
March 2026 | Delivery Insights: RJH Biosciences Contract Services
RJH Biosciences provides polymer-based transfection solutions supporting RNA and DNA delivery across cell lines, primary cells, and in vivo models. This edition highlights recent client
February 2026 | Advancing mRNA Delivery In Vivo: New Animal Study Results
Polymer-Based Solutions for Effective In Vivo mRNA Delivery At RJH Biosciences, we develop non-viral, polymer-based delivery platforms engineered for efficient and reproducible mRNA delivery across
January 2026 | Polymer-Based Solutions for Strong RNA and DNA Delivery Across Biological Systems
At RJH Biosciences, we develop non-viral, polymer-based transfection technologies optimized for delivery of nucleic acids across a wide range of modalities. Our platforms enable efficient